Literature DB >> 16971896

Serotonin receptor subtype mRNA expression in human ocular tissues, determined by RT-PCR.

Najam A Sharif1, Michelle Senchyna.   

Abstract

PURPOSE: To determine the relative density and tissue localization of mRNAs for serotonin (5-hydroxytryptamine; 5HT) receptor subtypes in human ocular tissues and correlate with their possible functions in the eye.
METHODS: Total RNA was extracted from human ocular tissues samples from multiple donors and transcribed into cDNA. An optimized reverse transcriptase polymerase chain reaction (RT-PCR) procedure was then used to amplify the signals using primers designed against human 5HT receptor cDNAs. The PCR products were analyzed by gel electrophoresis and confirmed by endonuclease digestion.
RESULTS: Variable amounts of total RNA were extracted from different tissues with the least amount from ciliary epithelium and most amount from retina. 5HT2 receptor subtype mRNAs were the most abundant with 5HT2A and 5HT2B being the most predominant in the retina, ciliary body, ciliary epithelium, choroid, conjunctiva, and iris. Ciliary body, choroid, and conjunctiva were most enriched in 5HT3 receptor mRNA, with relatively lower levels in the iris. 5HT4 receptor mRNA was most enriched in the retina, ciliary body, choroid, conjunctiva, and somewhat detectable in the iris. 5HT5 receptor mRNA was abundant in the retina, ciliary body, and iris. 5HT6 receptor mRNA was the least abundant of all subtypes studied and could only be detected in the iris. 5HT7 receptor mRNA was enriched in the ciliary body, choroid, conjunctiva, and iris, with much lower levels in the retina and ciliary epithelium. Optic nerve tissue of 1-2 donors exhibited the presence of 5HT2B, 5HT5, and 5HT7 receptor mRNAs. Data for human trabecular meshwork cells indicated a high density of mRNAs for 5HT2A and 5HT2B, with much lower levels of 5HT2C, 5HT5, and 5HT7 receptor mRNAs.
CONCLUSIONS: Human ocular tissues differentially expressed mRNAs for the various 5HT receptor subtypes. These studies suggest a diverse range of possible physiological and pharmacological functions of 5HT receptors in these human ocular tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971896

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  17 in total

1.  Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.

Authors:  Yu Chen; Grazyna Palczewska; Debarshi Mustafi; Marcin Golczak; Zhiqian Dong; Osamu Sawada; Tadao Maeda; Akiko Maeda; Krzysztof Palczewski
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

2.  Bilateral uveal effusions in a 23-year-old man.

Authors:  Karen W Jeng-Miller; Eric D Gaier; Angela V Turalba
Journal:  Digit J Ophthalmol       Date:  2018-05-22

3.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

4.  Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.

Authors:  Xujiao Zhou; Rong Zhang; Shenghai Zhang; Jihong Wu; Xinghuai Sun
Journal:  J Neurosci       Date:  2018-12-12       Impact factor: 6.167

Review 5.  Efferent influences on the bioelectrical activity of the retina in primates.

Authors:  Gonzalo Ortiz; J Vernon Odom; Christopher L Passaglia; Radouil T Tzekov
Journal:  Doc Ophthalmol       Date:  2016-12-28       Impact factor: 2.379

6.  Evaluation of the effects of duloxetine treatment on anterior segment parameters by optical coherence tomography.

Authors:  Murat A Özer; İlker F Sarı; Hakan Koç; Nurçe Ç Yavuz; Serkan Özen; Fazıl Kulaklı
Journal:  Int Ophthalmol       Date:  2022-07-07       Impact factor: 2.031

7.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

8.  Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker.

Authors:  L Noehr-Jensen; S T Zwisler; F Larsen; S H Sindrup; P Damkier; F Nielsen; K Brosen
Journal:  Eur J Clin Pharmacol       Date:  2009-04-29       Impact factor: 2.953

Review 9.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

10.  Effects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the rat.

Authors:  João Martins; Miguel Castelo-Branco; Ana Batista; Bárbara Oliveiros; Ana Raquel Santiago; Joana Galvão; Eduarda Fernandes; Félix Carvalho; Cláudia Cavadas; António F Ambrósio
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.